New schizophrenia drug could treat Alzheimer’s disease
Half a dozen drugs are in trials for conditions of the brain, but success is not guaranteed. ...
Half a dozen drugs are in trials for conditions of the brain, but success is not guaranteed. ...
The recently proposed U.S. Food and Drug Administration (FDA) guidance updated the agency’s expectations for the contents of informed consent forms for clinical trial participants. ...
All the time in the world is never enough time. You especially notice this when you don't know if you'll get another day....
Alzheimer’s trials face the unique challenge of studying participants with cognitive decline, amid a move towards digital technologies....
Today marks the final phase of new patient appointments at Eastpark....
Electronic methods of capture of clinical endpoint data are becoming increasingly dominant, and yet it’s notable that in some respects the industry continues to critique electronic methods in a way paper-based methods are not....
Findings from a small study suggest that more Black than White, Asian, or patients of other races distrust medical research and have spiritual beliefs about medical research....
Mass General Brigham, Emory and other providers, including the UW–Madison School of Medicine and Public Health, will assess different AI models from companies like Google, Microsoft and Amazon....
At two upcoming events on rare disease clinical trials and data management, experts will dissect the latest trends and discern ways to overcome sector challenges....
Women across the country are searching for answers to improve their health. They’re trying to manage flare-ups from autoimmune diseases. They’re dealing with chronic pain. They’re coping with postpartum depression. For these experiences and more, we still have much work to do....